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Background: The Ryanodine receptor 3 gene (RYR3) encodes an intracellular calcium channel that mediates the
efflux of Ca2+ from intracellular stores. Two single-nucleotide polymorphisms (SNPs) in the RYR3 gene have been
shown to associate with stroke (rs877087) and carotid intima-media thickness (rs2229116) in two independent
genome-wide association studies (GWAS) in Caucasian. We investigated the effect of these two SNPs as well as the
31.1 kilobases spanning region on atherosclerosis in Japanese population.
Methods: Atherosclerotic severity was assessed by carotid artery (n = 1374) and pathological atherosclerosis index
(PAI) (n = 1262), which is a macroscopic examination of the luminal surfaces of 8 systemic arteries in consecutive
autopsy samples. 4 tag SNPs in the 31.1 Kb region, rs877087, rs2132207, rs658750 and rs2229116, were genotyped
and haplotypes were inferred to study the association with atherosclerotic indices.
Results: rs877087 and rs2229116 were associated with PAI (OR = 2.07 [1.04-4.12] (95% CI), p = 0.038; and OR = 1.38
[1.02-1.86], p = 0.035, respectively). rs2229116 was also associated with common carotid atherosclerosis (OR = 1.45
[1.13-1.86], p = 0.003). The risk allele of rs2229116 was opposite from the original report. The haplotype block of this
31.1 Kb region was different between Caucasian and Japanese. Haplotype analysis revealed that only TAGG
haplotype was associated with PAI (OR = 0.67 [0.48-0.94], p = 0.020) and atherosclerosis of common carotid artery
(OR = 0.75 [0.58-0.98], p = 0.034).
Conclusion: rs877087 and rs2229116 of RYR3 gene are associated with atherosclerosis severity in Japanese. The
functional difference caused by rs2229116 needs to be investigated.
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Atherosclerosis is currently thought to be an inflamma-
tory disease with deposits of cholesterol and inflamma-
tory cells in the arterial wall [1-3]. In the later stages,
thrombosis forms, and this leads to fatal events, like
myocardial and cerebral infarctions [4,5]. The etiology of
atherosclerosis is multi-factorial, in that it includes vari-
ous genetic and environmental factors [6,7]. It is known
that genetic factors play a pivotal role in atherosclerosis,
but the influence of specific genes on susceptibility is
not fully understood [8-10]. The discovery of novel risk* Correspondence: muramatsu.epi@mri.tmd.ac.jp
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reproduction in any medium, provided the orfactors for atherosclerosis may lead to efficient preven-
tion and new therapeutic targets for this fatal disease.
Recently, two independent genome-wide association
studies (GWAS) of atherosclerotic diseases in Caucasians
pointed to two SNPs, closely resided in the 31.1 Kb (in-
tron 14 ~ exon 19) region of the RYR3 gene [11,12]. RYR3
gene is located on chromosome 15q14-q15, and encode a
large intracellular homotetrameric protein (> 2MDa) that
comprises 4780 amino acids [13-15]; RYR3 protein resides
on the sarcoplasmic reticulum membrane and releases
Ca2+ from intracellular stores to regulates intracellular
calcium concentration [16,17]. The RyR3-deficient mice
lack calcium regulation properties in arterial smooth
muscle cells, which lead to dysregulation of arterial tone
[18]. In human arterial endothelial cells, Ca2+ release me-
diated by RYR3, but not by the RYR1 and RYR2, plays atd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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able that RYR3 is a good candidate for atherosclerosis sus-
ceptible gene. The rs877087 polymorphism, which is an
intron SNP, was associated with stroke in a Caucasian
population from 4 large cohorts (n = 19,602) [11]. The
rs2229116, which is an Ile to Val non-synonymous SNP,
was associated with common carotid intima-media thick-
ness (cIMT), a clinical parameter for subclinical athero-
sclerosis [20]. This was found in a specific group of
Caucasian males infected with HIV and were treated with
highly active antiretroviral therapy (n = 177) [12]. Since
rs877087 and rs2229116 on RYR3 gene is separated by
31.1 Kb, we hypothesize that this region might confer sus-
ceptibility to atherosclerosis, and thus studied this region
in detail using tag SNPs and haplotypes.
Methods
Subjects
A total of 1536 consecutive autopsy cases of aged pa-
tients registered in the JG-SNP database were examined
(http://www.tmghig.jp/jg-snp/english/E_top.html) which
contains abundant pathological information on athero-
sclerosis [21]. The autopsies were performed from 1995
to 2004 at the Tokyo Metropolitan Geriatric Hospital in
Tokyo, Japan. The distribution of age at death is 65 ~
102 years old, and the mean is 80.21 ± 8.90 (mean ± SD).
The major clinical diagnosis and direct cause of death in
this Japanese population was described elsewhere [21].
The study was approved by the ethical committees of the
Tokyo Metropolitan Geriatric Hospital and the Tokyo
Medical and Dental University.
The methods for the pathological macroscopic evalu-
ation of atherosclerosis severity are published previously
[22,23]. Briefly, a total of eight arteries were examined,
including the common carotid artery, subclavian artery,
aorta, splenic artery, superior mesenteric artery, com-
mon iliac artery, external iliac artery, and femoral artery.
Assessments were performed by macroscopic examina-
tions of the luminal surface in formalin-fixed arteries. The
degree of atherosclerosis had been scored according to
the ratio of the atheroma area to the entire intimal area.
The scale ranged from 0–8, where 0 = absent, or a ratio
less than 1/20; 2 =minimal, or a ratio of 1/20 ~ 1/6; 4 =
mild, or a ratio of 1/6 ~ 1/3; 6 =moderate, or a ratio of
1/3 ~ 2/3; and 8 = severe, or a ratio of 2/3 ~ 1. The patho-
logical atherosclerotic index (PAI) was defined as the aver-
age degree of atherosclerotic severity in all eight arteries
[23]. Since not all eight arteries were evaluated in some
samples, the number of PAI records (n = 1262) is less than
the number of common carotid artery records (n = 1374).
Genetic analyses
The RYR3 polymorphism (rs877087, rs2132207, rs658750
and rs2229116) was analyzed by the Taqman assay(Applied BioSystems) using specific primers and probes
on a Light-Cycler 480 (Roche), according to previously de-
scribed protocols [24]. The pathological assessments and
genotyping were performed in different institutions in a
double-blind fashion.
Statistical analyses
Statistical analyses were performed with the IBM SPSS
19.0.0 statistical software. The associations of genotypes
with atherosclerosis severity were tested by multiple lo-
gistic regression analyses with adjustment for conven-
tional risk factors. All continuous and discrete variables
of atherosclerotic severity were categorized by the cut-
point of 75% severity, and divided subjects into Ath(+)
group with top 25% severity, and Ath(−) group with se-
verity lower than that, as we did previously [22]. The
conventional risk factors were also categorized as fol-
lows: gender (male vs. female), hypertension, diabetes
mellitus, hyperlipidemia, and history of smoking or
drinking (absent vs. present were classified as 0 vs. 1, re-
spectively). P-values less than 0.05 were considered sta-
tistically significant, and correction for multiple testing
was not considered in this study. Haplotype frequency
estimation and haplotype-based associations were per-
formed using PLINK software (http://pngu.mgh.harvard.
edu/purcell/plink/) [25]. Hardy–Weinberg equilibrium
(HWE) was determined with Fisher’s exact test. Linkage




rs877087 and rs2229116 is 31.1 Kb apart and the D’ and
r2 values of this susceptibility region in Japanese and
Caucasian were shown in Figure 1. The trends of LD
value showed that distinct difference of LD values could
be found in several SNP sites between two the popula-
tions (Figure 1). In order to investigate this region, two
tag SNPs (rs2132207 and rs658750, both are intron
SNPs) between rs877087 and rs2229116, were selected
by using Haploview software (pairwise tagging, r2 thresh-
old ≥ 0.1). Genotype and haplotype data of the four
RYR3 polymorphisms are summarized in Table 1. Five
major haplotypes (TGGA, TAGA, TAAA, TAGG and
TGGG) from the 4 SNPs could explain near 90% of the
genetic diversity constituted by these 4 SNPs in this re-
gion (Table 1).
Relationship between RYR3 polymorphisms and
atherosclerosis severity
Comparisons of atherosclerosis severity in each artery
for rs877087 and rs2229116 genotypes were performed
using Fisher’s exact test, and followed by logistic regres-
sion analysis in dominate or recessive models, adjusted
Figure 1 LD of SNPs between the 31.1 Kb region of rs877087 and rs2229116 in CEU and JPT. a: Comparison of D’ values (%) between CEU
and JPT. rs2229116 as reference SNP. Data were derived from HapMap. b: Comparison of r2 (%) values in this region.
Zhao et al. BMC Cardiovascular Disorders 2014, 14:6 Page 3 of 6
http://www.biomedcentral.com/1471-2261/14/6by gender, history of hyperlipidemia, hypertension, dia-
betes mellitus, drinking and smoking (Table 2). rs877087
T allele persisted significant association with PAI
(OR = 2.07, 95% CI = 1.04-4.12, p = 0.038) after adjust-
ment for conventional risk factors. Also, rs2229116 A
allele present significant associations with PAI (OR = 1.38,
95% CI = 1.02-1.86, p = 0.035) and atherosclerosis inTable 1 Genotype and haplotype distribution of the SNPs
rsSNPs Genotypes, n(%) P-value for HWE test
rs877087 TT CT CC 0.102
1279(94.2) 76(5.6) 3(0.2)
rs2132207 GG AG AA 0.443
463(34.2) 668(49.4) 221(16.4)
rs658750 GG AG AA 0.629
978(72.2) 349(25.8) 28(2.0)
rs2229116 AA AG GG 0.191
923(66.4) 411(29.5) 57(4.1)
Haplotypes Estimated frequencies and number of samplesa
TGGA 0.504, n = 681
TAGA 0.158, n = 214
TAAA 0.121, n = 164
TAGG 0.102, n = 138
TGGG 0.057, n = 77
aFrequencies of haplotypes were estimated using PLINK software.common carotid arteries (OR = 1.45, 95% CI = 1.13-
1.86, p = 0.003) after adjustment. The two tag SNPs,
rs2132207 and rs658750, are not significantly associ-
ated with PAI and atherosclerosis in common carotid
arteries (Additional file 1: Table S1). Subgroup analysis
of sex (male/female) for rs877087 and rs2229116
showed that, rs2229116 A allele present significant asso-
ciations with PAI and common carotid arteries only in
males (Table 2). Additional age subgroup analysis for
rs877087 and rs2229116 showed that rs877087 T allele
persisted significant association with PAI only in sub-
group age above 80; rs2229116 A allele present signifi-
cant associations with PAI in subgroup age below 80
and with common carotid arteries in subgroup age above
80 (Additional file 2: Table S2).
Atherosclerosis degrees in each rs2229116 genotype
The tendency from the means of atherosclerosis degree
in three genotypes of rs2229116, showed that risk allele
is the A allele in both PAI and common carotid arteries
in our samples (Table 3). In common carotid arteries,
statistically significant p-values were observed from
ANOVA test (p = 0.030) and from linear regression test
(p = 0.010), indicating that there is significant linear rela-
tionship between degree of atherosclerosis and the
rs2229116 polymorphism. Also, in PAI, the same trend
was seen with regard to the genotype but it was not sta-
tistically significant (p = 0.060) (Table 3).
Table 2 Relationship between RYR3 polymorphisms and atherosclerosis severity >75%
Arteries Ath
(+/−)
rs877087 genotypes, n(%) rs2229116 genotypes, n(%)
TT CT CC TT vs. CT + CC AA AG GG AA vs. AG + GG
pa OR(95% CI)b pb pa OR(95% CI)b pb
PAI + 319(96.4%) 11(3.3%) 1(0.3%) 0.023 2.07 0.038 241(71.5%) 84(24.9%) 12(3.6%) 0.008 1.38 0.035
(Total) - 840(93.2%) 59(6.6%) 2(0.2%) (1.04–4.12) 593(64.1%) 292(31.6%) 40(4.3%) (1.02–1.86)
Common carotid + 666(94.7%) 35(5.0%) 2(0.3%) 0.214 1.31 0.294 501(69.9%) 190(26.5%) 26(3.6%) 0.003 1.45 0.003
- 597(93.5%) 40(6.3%) 1(0.2%) (0.79–2.15) 412(62.7%) 214(32.6%) 31(4.7%) (1.13–1.86)(Total)
PAI + 183(96.3%) 7(3.7%) 0(0%) 0.061 1.87 0.164 140(71.8%) 47(24.1%) 8(4.1%) 0.042 1.58 0.026
(Male) - 440(92.8%) 33(7.0%) 1(0.2%) (0.78–4.52) 315(64.5%) 153(31.4%) 20(4.1%) (1.06–2.38)
Common carotid + 381(94.1%) 23(5.7%) 1(0.2%) 0.533 1.11 0.754 297(71.4%) 103(24.8%) 16(3.8%) 0.005 1.63 0.004
- 295(93.9%) 19(6.1%) 0(0%) (0.57–2.16) 201(62.0%) 108(33.3%) 15(4.7%) (1.17–2.27)(Male)
PAI + 136(96.5%) 4(2.8%) 1(0.7%) 0.151 2.39 0.124 101(71.1%) 37(26.1%) 4(2.8%) 0.062 1.23 0.374
(Female) - 400(93.7%) 26(6.1%) 1(0.2%) (0.79–7.27) 278(63.6%) 139(31.8%) 20(4.6%) (0.78–1.93)
Common carotid + 285(95.6%) 12(4.0%) 1(0.3%) 0.127 1.55 0.267 204(67.8%) 87(28.9%) 10(3.3%) 0.139 1.25 0.234
- 302(93.2%) 21(6.5%) 1(0.3%) (0.72–3.37) 211(63.4%) 106(31.8%) 16(4.8%) (0.86–1.82)(Female)
ap-value from Fisher’s exact test, 1-sided.
bp-value and odds ratio from logistic regression test after adjusted by gender, history of hyperlipidemia, hypertension, diabetes mellitus, drinking, and smoking.
(Parameter of gender was excluded for adjustment in Male and Female subgroups).
p-values less than 0.05 were marked in bold.
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atherosclerosis severity
From haplotype linear regression test, positive beta
values were observed in the TGGA haplotype group in
common carotid arteries (beta = 0.34, p = 0.032) and ob-
served in the TAAA haplotype group in PAI (beta =
0.50, p = 0.048). Also, a negative beta value was observed
in TAGG haplotype group in common carotid arteries
(beta = −0.70, p = 0.007) (Table 4). Logistic regression test
of haplotype association was performed for atherosclerosis
severity >75%. In TAGG haplotype group, significant pre-
ventive odds ratio were observed in common carotid ar-
teries (p = 0.034, OR = 0.75; 95% CI, 0.58-0.98), and in PAI
(p = 0.020, OR = 0.67; 95% CI, 0.48-0.94) (Table 4).
Discussion
The previous GWAS showed that the RYR3 gene poly-
morphisms rs877087 and rs2229116 was associated with
stroke and cIMT, respectively [11,12]. In this study, we
investigated these two SNPs on RYR3 gene and the 31.1
Kb region in between employing elderly Japanese. We
observed that both rs877087 and rs2229116 was associated
with PAI. Our study suggested that the atherosclerosis riskTable 3 Means of atherosclerosis degrees in rs2229116 genot
Arteries rs2
AA AG
Common carotid 7.18 (913) 6.63 (404)
PAI 4.29 (834) 4.15 (376)
ap value from ANOVA test for means of three genotype groups.
bp value from linear regression test for means of three genotype groups.
p-values less than 0.05 were marked in bold.allele is T for rs877087, as the same risk allele from the
GWAS of stroke. It should be noted that the minor allele
frequency of rs877087 is 0.035 for C allele in Japanese, and
0.42 for T allele in Caucasian according to the HapMap
data. rs2229116 was associated with PAI and atherosclerosis
severity in common carotid after adjusted for conventional
risk factors (Table 2). However, our risk allele was opposite
from the original paper [12], in that, the GWAS for cIMT
the risk allele was G, but in our study it was A (Table 3).
The LD patterns between rs877087 and rs2229116 from
HapMap data showed great differences between CEU
and JPT (Figure 1 and Additional file 3: Figure S1 and
Additional file 4: Figure S2). As reference to rs2229116, the
LD values of two populations showed large difference
(ΔD’ > 0.5) in several SNP sites, including the 2 tag SNPs
(rs2132207 and rs658750), suggesting that the haplotypes
within this region may be different between CEU and JPT
(Figure 1). Therefore, different haplotypes might account
for the different observation between Japanese and
European. In order to further investigate the region be-
tween the two reported SNPs, we further selected 2 tag
SNPs (rs2132207 and rs658750) and build haplotypes
(Table 1). Haplotype linear regression analyses revealedype groups
229116 genotypes, mean(n)
GG Total pa pb
6.42 (57) 6.99 (1374) 0.030 0.010
3.97 (52) 4.23 (1262) 0.171 0.060
Table 4 Haplotype-based association test for linear and logistic regression
Common carotid PAI
Haplotype BETAa pa OR(95% CI)b pb BETAa pa OR(95% CI)b pb
TGGA 0.34 0.032 1.16(0.99–1.36) 0.071 −0.18 0.292 1.07(0.89–1.28) 0.464
TAGA 0.27 0.194 1.12(0.90–1.40) 0.314 −0.11 0.611 1.15(0.90–1.47) 0.265
TAAA −0.25 0.296 1.02(0.75–1.39) 0.901 0.50 0.048 1.19(0.91–1.55) 0.201
TAGG −0.70 0.007 0.75(0.58–0.98) 0.034 −0.14 0.603 0.67(0.48–0.94) 0.020
TGGG −0.61 0.109 0.61(0.41–0.90) 0.013 −0.09 0.813 0.75(0.47–1.22) 0.247
aBETA and p-value from haplotype-based linear regression test.
bOdds ratio and p-value from haplotype-based logistic regression test for atherosclerosis serverity > 75%.
p-values less than 0.05 were marked in bold.
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of atherosclerosis severity in both common carotid arter-
ies and PAI. Also, an increase trend was observed in
TGGA haplotype in common carotid arteries and TAAA
haplotypes in PAI, respectively (Table 4). In haplotype lo-
gistic regression model for atherosclerosis severity trait,
we observed TAGG haplotype had a preventive effect in
both common carotid arteries and PAI (Table 4). Al-
though we tried to explain the opposite effect in Japanese
and Caucasian, using trans-ethnic fine mapping, and se-
lected these two tag SNPs which gave a significant differ-
ence in LD value between two ethnics, we could not
explain the association with either of the SNP. Neverthe-
less, taken together the results of haplotype analysis, it is
likely that the non-synonymous polymorphism rs2229116
(Val/Ile) itself may be the primary determinant for the
observed associations (Table 4).
The rs2229116 SNP causes amino acid substitution
(Ile to Val) at the 731st amino acid site of RYR3. How-
ever, the functional consequence has not yet been inves-
tigated. RYR3 have a major role in calcium signaling in
the vasculation and thus is a good candidate gene in ath-
erosclerosis pathogenesis.
Along with the function of RYR3 in vascular cells, re-
cent studies have found that RYR3 have function in T
cells, which is involved in the inflammation process of
atherosclerotic lesions [27,28]. RYR3 appear to regulate
Ca2+ signaling in T lymphocytes [29], in which, calcium
signaling is essential for its activation and differentiation
[30]. The association of T cell activation markers and ca-
rotid arterial stiffness was also reported in a group of
HIV-infected women [31]. These lines of evidence suggest
that, intracellular calcium mobilization mediated by RYR3
may be involved in atherosclerosis process through its
common participants, such as arterial smooth muscle
cells, endothelial cells and T lymphocytes.
Our study has some limitations. The subjects of the
present study were consecutive autopsy cases of patients
in a geriatric hospital. Therefore, the selection bias and
whether the subjects can represent the demographics of
Japan should be evaluated. The autopsy rate of the hospitalwas kept around 40% and those who died suddenly outside
the hospital and medicolegal cases were not autopsied for
this study. The leading mortality probability at the age of 75
years according the census data in ‘Abridged Life Tables For
Japan 2010’ by the Ministry of Health, Labor and Welfare
of Japan (http://www.mhlw.go.jp/english/database/db-hw/
lifetb10/index.html) were as follows; 25.9% men vs. 16.5%
women by malignant neoplasms, 15.2% men vs. 20.3%
women by heart diseases, 10.4% men vs. 12.1% women by
cerebrovascular diseases, and 15.3% men vs. 12.4% women
by pneumonia. Almost all death rates for major diseases at
75 years of age in Tokyo were consistent with our autopsy
data, except for the frequency of malignant neoplasms is a
little higher and that of cerebrovascular diseases is lower in
our autopsy subjects. Since the national health insurance
covers the whole population of Japan and in Japan most
death occurred in hospitals, the selection bias from socio-
economic difference of the subjects seems minimal.
Altogether, the subjects in our study did not differ greatly
from the standard elderly residents in Tokyo, and may rep-
resent the general population, including young residents, in
Japan rather than a selected hospitalized population.
Conclusions
RYR3 gene rs877087 and rs2229116 polymorphisms are as-
sociated with atherosclerosis in elderly Japanese. Functional
studies are still needed to identify the causal variation.
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